Back to results
US 10,767,158 B2Granted
Bioprotection using lactobacillus paracasei strains
AssigneeChr. Hansen A/S
InventorsTina Hornbaek, Maike Lisberg, Silja Kej Diemer
Life of this patent
Estimating the term…
Loading patent…
Loading patent…
AssigneeChr. Hansen A/S
InventorsTina Hornbaek, Maike Lisberg, Silja Kej Diemer
Estimating the term…
The present invention is related to the field of bioprotection, in particular to the strain of Lactobacillus paracasei CHCC14676 with accession no. DSM25612. Furthermore, the present invention concerns an antifungal composition comprising the strain, an antifungal composition comprising the strain and at least one strain of Lactobacillus rhamnosus, food, feed and pharmaceutical products comprising such an antifungal composition, a method of manufacturing such food, feed and pharmaceutical products, a method for reducing the content of yeasts and molds of such food, feed and pharmaceutical products and uses of the antifungal composition.
An antifungal composition comprising at least one Lactobacillus paracasei strain selected from Lactobacillus paracasei strain CHCC14676 (DSM25612) and mutant strains derived therefrom, wherein the mutant strains have substantially the same or improved antifungal properties as CHCC14676 (DSM25612), wherein the Lactobacillus paracasei strain is capable of inhibiting or preventing the growth of Mucor spp, and wherein the composition comprises an amount of the at least one Lactobacillus paracasei strain effective to inhibit growth of yeasts and molds in the composition and further comprises an effective amount of an added cryoprotectant for the at least one Lactobacillus paracasei strain.
A food, feed or pharmaceutical product, comprising at least one Lactobacillus paracasei strain selected from Lactobacillus paracasei strain CHCC14676 (DSM25612) and mutant strains derived therefrom and an effective amount of an added cryoprotectant for the at least one Lactobacillus paracasei strain, wherein the mutant strains have substantially the same or improved antifungal properties as CHCC14676 (DSM25612), the Lactobacillus paracasei strain is capable of inhibiting or preventing the growth of Mucor spp., and the food, feed or pharmaceutical product comprises an amount of the at least one Lactobacillus paracasei strain effective to inhibit growth of yeasts and molds in the food, feed or pharmaceutical product.
A food, feed or pharmaceutical product made by a process comprising adding at least one Lactobacillus paracasei strain selected from Lactobacillus paracasei strain CHCC14676 (DSM25612) and mutant strains derived therefrom and an effective amount of an added cryoprotectant for the at least one Lactobacillus paracasei strain to a food, feed or pharmaceutical product during manufacture in an amount effective to inhibit growth of yeasts and molds in the food, feed or pharmaceutical product, wherein the mutant strains have substantially the same or improved antifungal properties as CHCC14676 (DSM25612), and wherein the Lactobacillus paracasei strain is capable of inhibiting or preventing the growth of Mucor spp.
Dependencies are inferred from the claim text.